Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Logo for

Science 311 (5757): 77-80

Copyright © 2006 by the American Association for the Advancement of Science

Alterations in 5-HT1B Receptor Function by p11 in Depression-Like States

Per Svenningsson,1,2 Karima Chergui,2 Ilan Rachleff,1 Marc Flajolet,1 Xiaoqun Zhang,2 Malika El Yacoubi,3 Jean-Marie Vaugeois,3 George G. Nomikos,4 Paul Greengard1*

Abstract: The pathophysiology of depression remains enigmatic, although abnormalities in serotonin signaling have been implicated. We have found that the serotonin 1B receptor [5-hydroxytryptamine (5-HT1B) receptor] interacts with p11. p11 increases localization of 5-HT1B receptors at the cell surface. p11 is increased in rodent brains by antidepressants or electroconvulsive therapy, but decreased in an animal model of depression and in brain tissue from depressed patients. Overexpression of p11 increases 5-HT1B receptor function in cells and recapitulates certain behaviors seen after antidepressant treatment in mice. p11 knockout mice exhibit a depression-like phenotype and have reduced responsiveness to 5-HT1B receptor agonists and reduced behavioral reactions to an antidepressant.

1 Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10021, USA.
2 Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
3 Unite de Neuropsychopharmacologie Experimentale—CNRS FRE2735, European Institute for Peptide Research (IFRMP 23), Faculty of Medicine and Pharmacy, Rouen F76183 Cedex, France.
4 Neuroscience Discovery Research, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.

* To whom correspondence should be addressed, E-mail: greengard{at}

Pivotal role of tissue plasminogen activator in the mechanism of action of electroconvulsive therapy.
S. Hoirisch-Clapauch, M. A. Mezzasalma, and A. E. Nardi (2014)
J Psychopharmacol 28, 99-105
   Abstract »    Full Text »    PDF »
Modulation of Neurotransmission by GPCRs Is Dependent upon the Microarchitecture of the Primed Vesicle Complex.
E. Hamid, E. Church, C. A. Wells, Z. Zurawski, H. E. Hamm, and S. Alford (2014)
J. Neurosci. 34, 260-274
   Abstract »    Full Text »    PDF »
Transcriptome study of differential expression in schizophrenia.
A. R. Sanders, H. H. H. Goring, J. Duan, E. I. Drigalenko, W. Moy, J. Freda, D. He, J. Shi, MGS, and P. V. Gejman (2013)
Hum. Mol. Genet. 22, 5001-5014
   Abstract »    Full Text »    PDF »
Multiple serotonergic paths to antidepressant efficacy.
P.-E. Lutz (2013)
J Neurophysiol 109, 2245-2249
   Abstract »    Full Text »    PDF »
A Noncanonical Postsynaptic Transport Route for a GPCR Belonging to the Serotonin Receptor Family.
T. Liebmann, M. Kruusmagi, N. Sourial-Bassillious, A. Bondar, P. Svenningsson, M. Flajolet, P. Greengard, L. Scott, H. Brismar, and A. Aperia (2012)
J. Neurosci. 32, 17998-18008
   Abstract »    Full Text »    PDF »
Next-Generation Treatments for Mental Disorders.
T. R. Insel (2012)
Science Translational Medicine 4, 155ps19
   Full Text »    PDF »
Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior.
J. L. Warner-Schmidt, E. F. Schmidt, J. J. Marshall, A. J. Rubin, M. Arango-Lievano, M. G. Kaplitt, I. Ibanez-Tallon, N. Heintz, and P. Greengard (2012)
PNAS 109, 11360-11365
   Abstract »    Full Text »    PDF »
Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA).
B. Di Cara, R. Maggio, G. Aloisi, J.-M. Rivet, E. G. Lundius, T. Yoshitake, P. Svenningsson, M. Brocco, A. Gobert, L. De Groote, et al. (2011)
J. Neurosci. 31, 16928-16940
   Abstract »    Full Text »    PDF »
Regulation of fibrinolysis by S100A10 in vivo.
A. P. Surette, P. A. Madureira, K. D. Phipps, V. A. Miller, P. Svenningsson, and D. M. Waisman (2011)
Blood 118, 3172-3181
   Abstract »    Full Text »    PDF »
Cell-Type-Specific Modulation of Feedback Inhibition by Serotonin in the Hippocampus.
J. Winterer, A. V. Stempel, T. Dugladze, C. Foldy, N. Maziashvili, A. R. Zivkovic, J. Priller, I. Soltesz, T. Gloveli, and D. Schmitz (2011)
J. Neurosci. 31, 8464-8475
   Abstract »    Full Text »    PDF »
Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans.
J. L. Warner-Schmidt, K. E. Vanover, E. Y. Chen, J. J. Marshall, and P. Greengard (2011)
PNAS 108, 9262-9267
   Abstract »    Full Text »    PDF »
Serotonin, cytokines, p11, and depression.
S. H. Snyder (2011)
PNAS 108, 8923-8924
   Full Text »    PDF »
Differential Binding of Calmodulin to Group I Metabotropic Glutamate Receptors Regulates Receptor Trafficking and Signaling.
K. Y. Choi, S. Chung, and K. W. Roche (2011)
J. Neurosci. 31, 5921-5930
   Abstract »    Full Text »    PDF »
Counseling African Americans in Cardiac Rehabilitation: Implications for Comprehensive Lifestyle Modification.
N. T. Artinian and B. Franklin (2010)
American Journal of Lifestyle Medicine 4, 490-499
   Abstract »    PDF »
Kinetics of G-protein-coupled receptor endosomal trafficking pathways revealed by single quantum dots.
K. M. Fichter, M. Flajolet, P. Greengard, and T. Q. Vu (2010)
PNAS 107, 18658-18663
   Abstract »    Full Text »    PDF »
p11 and Gene Therapy for Severe Psychiatric Disorders: A Practical Goal?.
G. Chen, R. Twyman, and H. K. Manji (2010)
Science Translational Medicine 2, 54ps51
   Full Text »    PDF »
Reversal of Depressed Behaviors in Mice by p11 Gene Therapy in the Nucleus Accumbens.
B. Alexander, J. Warner-Schmidt, T. M. Eriksson, C. Tamminga, M. Arango-Lievano, S. Ghose, M. Vernov, M. Stavarache, S. Musatov, M. Flajolet, et al. (2010)
Science Translational Medicine 2, 54ra76
   Abstract »    Full Text »    PDF »
Serotonin shapes risky decision making in monkeys.
A. B. Long, C. M. Kuhn, and M. L. Platt (2009)
Soc Cogn Affect Neurosci 4, 346-356
   Abstract »    Full Text »    PDF »
Regulation of Serotonin 1B Receptor by Glycogen Synthase Kinase-3.
L. Chen, G. D. Salinas, and X. Li (2009)
Mol. Pharmacol. 76, 1150-1161
   Abstract »    Full Text »    PDF »
[N-methyl-3H3]AZ10419369 Binding to the 5-HT1B Receptor: In Vitro Characterization and in Vivo Receptor Occupancy.
D. L. Maier, C. Sobotka-Briner, M. Ding, M. E. Powell, Q. Jiang, G. Hill, J. R. Heys, C. S. Elmore, M. E. Pierson, and L. Mrzljak (2009)
J. Pharmacol. Exp. Ther. 330, 342-351
   Abstract »    Full Text »    PDF »
Reverse translational strategies for developing animal models of bipolar disorder.
O. Malkesman, D. R. Austin, G. Chen, and H. K. Manji (2009)
Dis. Model. Mech. 2, 238-245
   Abstract »    Full Text »    PDF »
Striatal Alterations of Secretogranin-1, Somatostatin, Prodynorphin, and Cholecystokinin Peptides in an Experimental Mouse Model of Parkinson Disease.
A. Nilsson, M. Falth, X. Zhang, K. Kultima, K. Skold, P. Svenningsson, and P. E. Andren (2009)
Mol. Cell. Proteomics 8, 1094-1104
   Abstract »    Full Text »    PDF »
Role of p11 in Cellular and Behavioral Effects of 5-HT4 Receptor Stimulation.
J. L. Warner-Schmidt, M. Flajolet, A. Maller, E. Y. Chen, H. Qi, P. Svenningsson, and P. Greengard (2009)
J. Neurosci. 29, 1937-1946
   Abstract »    Full Text »    PDF »
Targeting of the 5-HT1A Serotonin Receptor to Neuronal Dendrites Is Mediated by Yif1B.
D. Carrel, J. Masson, S. Al Awabdh, C. B. Capra, Z. Lenkei, M. Hamon, M. B. Emerit, and M. Darmon (2008)
J. Neurosci. 28, 8063-8073
   Abstract »    Full Text »    PDF »
Protein-Protein Interactions and Dopamine D2 Receptor Signaling: A Calcium Connection.
G. D. Stanwood (2008)
Mol. Pharmacol. 74, 317-319
   Abstract »    Full Text »    PDF »
Endothelial Cell Annexin A2 Regulates Polyubiquitination and Degradation of Its Binding Partner S100A10/p11.
K.-L. He, A. B. Deora, H. Xiong, Q. Ling, B. B. Weksler, R. Niesvizky, and K. A. Hajjar (2008)
J. Biol. Chem. 283, 19192-19200
   Abstract »    Full Text »    PDF »
Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism.
X. Zhang, P. E. Andren, P. Greengard, and P. Svenningsson (2008)
PNAS 105, 2163-2168
   Abstract »    Full Text »    PDF »
S100A16, a Novel Calcium-binding Protein of the EF-hand Superfamily.
E. Sturchler, J. A. Cox, I. Durussel, M. Weibel, and C. W. Heizmann (2006)
J. Biol. Chem. 281, 38905-38917
   Abstract »    Full Text »    PDF »
Deletion of Annexin 2 Light Chain p11 in Nociceptors Causes Deficits in Somatosensory Coding and Pain Behavior.
T. Foulkes, M. A. Nassar, T. Lane, E. A. Matthews, M. D. Baker, V. Gerke, K. Okuse, A. H. Dickenson, and J. N. Wood (2006)
J. Neurosci. 26, 10499-10507
   Abstract »    Full Text »    PDF »
Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells.
J.-M. Launay, B. Schneider, S. Loric, M. Da Prada, and O. Kellermann (2006)
FASEB J 20, 1843-1854
   Abstract »    Full Text »    PDF »
New Antidepressant Protein Helps Serotonin Work Better.
Journal Watch Psychiatry 2006, 4
   Full Text »
NEUROSCIENCE: A New Molecule to Brighten the Mood.
T. Sharp (2006)
Science 311, 45-46
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882